|
|
The Neuroprotective Effects of Sulforaphane in VPA-Induced Models of Autism |
| 1R21AT011371-01A1 |
|
NCCIH |
2022 |
|
|
Online EZY Tai Chi: Simplified 8-Form Program for Individuals with Intellectual Disabilities |
| 1R43AT011836-01A1 |
|
NCCIH |
2022 |
|
|
Neural Mechanisms of Mindfulness-Based Stress Reduction in Adults with Autism Spectrum Disorder |
| 5F31AT010976-02 |
|
NCCIH |
2022 |
|
|
Fatty acid supplements alter biological signatures in children with Autism Spectrum Disorder |
| 5R33AT009632-05 |
|
NCCIH |
2022 |
|
|
Neuropsychological Profiles and Risk for Dementia-Related Disease in Mothers of Children with Autism Spectrum Disorder |
| 1F32AG079615-01 |
|
NIA |
2022 |
|
|
Iron Metabolism in Ts65Dn mice, a Model of Down syndrome |
| 1R15AG077421-01 |
|
NIA |
2022 |
|
|
Restoration of proteostasis to address co-occurring conditions in Down Syndrome |
| 1RF1AG078969-01 |
|
NIA |
2022 |
|
|
The role of APP in neurogenesis and AD in Down syndrome |
| 1RF1AG079002-01 |
|
NIA |
2022 |
|
|
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome |
| 3R01AG064579-03S1 |
|
NIA |
2022 |
|
|
Down Syndrome: Toward Optimal Trajectories and Health Equity using Medicaid Analytic eXtract (DS -TO-THE-MAX) |
| 3R01AG073179-01S1 |
|
NIA |
2022 |